-The Economist West Bengal’s populist chief minister is doing badly. Yet she typifies shifts in power in India BUYER’S remorse is common enough in the dusty markets of Kolkata, a delightful if crumbling great city, once known as Calcutta and still capital of the state of West Bengal. Those who buy cheap plastic goods or plaster-of-Paris busts of Rabindranath Tagore, Bengal’s cultural hero, may come to regret their haste. Likewise, many who...
More »SEARCH RESULT
NREGA: Wages are often denied or delayed, with corruption rife-Inayat Sabhikhi
-The Economic Times Shibu Joseph ( Why I am Quitting my Job, ET, March 29) suggests, tongue-in-cheek, that he should quit the drudgery of corporate life and, instead, enjoy the "freebies" given to the aam aadmi, like the right to work under the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA). I am not going to write on behalf of the crores of people who work in this programme, because I am...
More »Microfinance institutions escape charge of abetting suicide of clients-M Suchitra
In 2010, Andhra Pradesh witnessed a series of suicides. These were not cases of farmers' suicides—a regular occurrence in the state which continues to be in the grip of an agrarian crisis. The victims in these cases happened to be the poorest of the poor; most of them illiterate dalits and adivasis. The first information reports (FIRs) of the police reveal that most of the suicides were due to coercive...
More »Western warnings-R Ramachandran
India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...
More »Question of efficacy -Leena Menghaney
The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...
More »